Radical inguinal orchiectomy for testicular germ cell tumors

INTRODUCTION

Testicular cancers, 95 percent of which are germ cell tumors, have become one of the most curable solid neoplasms because of remarkable treatment advances that began in the late 1970s. Prior to that time, testicular cancer accounted for 11 percent of all cancer deaths in men between the ages of 25 to 34, and the five-year survival rate was 64 percent [1]. Now, the five-year survival rate is over 95 percent for both seminoma and nonseminomatous germ cell tumors (NSGCTs) (table 1) [2], and testicular cancer is responsible for fewer than 400 deaths annually in the United States [3].

These improvements in outcome are related to a better understanding of the natural history of testicular tumors, improved staging and surgical techniques, the use of tumor markers to guide patient management, and the introduction of effective platinum-based combination chemotherapy [1,4,5]. The consistently high cure rates in early stage disease have resulted in a shift in focus toward reducing treatment-related effects on reproductive function, as well as the toxicities associated with chemotherapy and radiation. (See "Treatment-related toxicity in men with testicular germ cell tumors".)

Radical orchiectomy for the diagnosis and treatment of men with suspected testicular cancer is discussed here. An overview of the management of testicular cancer is presented separately. (See "Overview of the treatment of testicular germ cell tumors".)

SURGICAL TREATMENT OF THE TESTIS

The decision to proceed with operative intervention in a man with a suspected testicular cancer is made after careful consideration of all available data, including the clinical findings, imaging studies, and serum tumor markers. Although frequently used to support a clinical suspicion of testicular cancer, scrotal ultrasound of a testicular mass cannot replace surgical and histologic examination of the testis based upon radical inguinal orchiectomy. (See "Clinical manifestations, diagnosis, and staging of testicular germ cell tumors".)

Radical inguinal orchiectomy — Radical inguinal orchiectomy with high ligation of the spermatic cord at the level of internal ring is the procedure of choice for suspected testicular cancer.

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Einhorn, LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990; 8:1777.
  2. Ries, LA, Eisner, MP, Kosary, CL, et al. SEER Cancer Statistics Review, 1975-2001, National Cancer Institute, Bethesda, MD, 2004.
  3. Jemal, A, Siegel, R, Ward, E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225.
  4. Bosl, GJ, Motzer, RJ. Testicular germ-cell cancer [published erratum appears in N Engl J Med 1997 Nov 6;337(19):1403]. N Engl J Med 1997; 337:242.
  5. Levin, HS. Prognostic features of primary and metastatic testis germ-cell tumors. Urol Clin North Am 1993; 20:39.
  6. Adshead, J, Khoubehi, B, Wood, J, Rustin, G. Testicular implants and patient satisfaction: a questionnaire-based study of men after orchidectomy for testicular cancer. BJU Int 2001; 88:559.
  7. Turek, PJ, Master, VA. Safety and effectiveness of a new saline filled testicular prosthesis. J Urol 2004; 172:1427.
  8. Leibovitch, I, Little, JS Jr, Foster, RS, et al. Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors. J Urol 1996; 155:952.
  9. Simmonds, PD, Mead, GM, Lee, AH, et al. Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?. Cancer 1995; 75:1018.
  10. Greist, A, Einhorn, LH, Williams, Sd, et al. Pathologic findings at orchiectomy following chemotherapy for disseminated testicular cancer. J Clin Oncol 1984; 2:1025.
  11. Ondrus, D, Hornak, M, Breza, J, et al. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer. Int Urol Nephrol 2001; 32:665.
  12. Ramani, VA, Grey, BR, Addla, SK, et al. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis. Clin Oncol (R Coll Radiol) 2008; 20:247.
  13. Geldart, TR, Simmonds, PD, Mead, GM. Orchidectomy after chemotherapy for patients with metastatic testicular germ cell cancer. BJU Int 2002; 90:451.
  14. Chong, C, Logothetis, CJ, von Eschenbach, A, et al. Orchiectomy in advanced germ cell cancer following intensive chemotherapy: a comparison of systemic to testicular response. J Urol 1986; 136:1221.
  15. Giguere, JK, Stablein, DM, Spaulding, JT, et al. The clinical significance of unconventional orchiectomy approaches in testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol 1988; 139:1225.
  16. Capelouto, CC, Clark, PE, Ransil, BJ, Loughlin, KR. A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?. J Urol 1995; 153:981.
  17. Pizzocaro, G, Zanoni, F, Salvioni, R, et al. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 1987; 138:1393.
  18. Kennedy, CL, Hendry, WF, Peckham, MJ. The significance of scrotal interference in stage I testicular cancer managed by orchiectomy and surveillance. Br J Urol 1986; 58:705.
  19. Thomas, GM, Sturgeon, JF, Alison, R, et al. A study of post-orchiectomy surveillance in stage I testicular seminoma. J Urol 1989; 142:313.
  20. Heidenreich, A, Holtl, W, Albrecht, W, et al. Testis-preserving surgery in bilateral testicular germ cell tumours. Br J Urol 1997; 79:253.
  21. Yossepowitch, O, Baniel, J. Role of organ-sparing surgery in germ cell tumors of the testis. Urology 2004; 63:421.
  22. Schmoll, HJ, Souchon, R, Krege, S, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15:1377.
  23. Sonneveld, DJ, Schraffordt Koops, H, Sleijfer, DT, Hoekstra, HJ. Bilateral testicular germ cell tumours in patients with initial stage I disease: prevalence and prognosis--a single centre's 30 years' experience. Eur J Cancer 1998; 34:1363.
  24. Holzbeierlein, JM, Sogani, PC, Sheinfeld, J. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering cancer center experience 1950 to 2001. J Urol 2003; 169:2122.
  25. Che, M, Tamboli, P, Ro JY, et al. Bilateral testicular germ cell tumors. Cancer 2002; 95:1228.
  26. Dieckmann, KP, Skakkebaek, NE, et al. Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer 1999; 83:815.
  27. Connolly, SS, D'Arcy, FT, Bredin, HC, et al. Value of frozen section analysis with suspected testicular malignancy. Urology 2006; 67:162.
  28. Heidenreich, A, Weissbach, L, Holtl, W, et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001; 166:2161.
white circle LOG IN
white circle DEMO